In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Juno Therapeutics,
Inc. (NASDAQ:JUNO), Abbott Laboratories (NYSE:ABT),
Freeport-McMoran, Inc. (NYSE:FCX), HP Inc. (NYSE:HPQ), The Trade
Desk Inc. (NASDAQ:TTD), and Platform Specialty Products Corporation
(NYSE:PAH), including updated fundamental summaries, consolidated
fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
JUNO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=JUNO
ABT DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ABT
FCX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=FCX
HPQ DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HPQ
TTD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TTD
PAH DOWNLOAD:
http://Fundamental-Markets.com/register/?so=PAH
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Juno Therapeutics, Inc. (NASDAQ:JUNO), Abbott Laboratories
(NYSE:ABT), Freeport-McMoran, Inc. (NYSE:FCX), HP Inc. (NYSE:HPQ),
The Trade Desk Inc. (NASDAQ:TTD), and Platform Specialty Products
Corporation (NYSE:PAH) on a fundamental level and outlines the
overall demand for their products and services in addition to an
in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the
recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 24th, 2017.
Please download the entire research report, free of charge, to
ensure you are reading all relevant material information. All
amounts in millions (MM), except per share amounts. Percentage
calculations are performed after rounding.
-----------------------------------------
JUNO THERAPEUTICS, INC. (JUNO) REPORT
OVERVIEW
Juno Therapeutics' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Juno Therapeutics reported revenue of
$44.82MM vs $20.83MM (up 115.19%) and diluted earnings per share
-$1.12 vs -$0.56. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Juno Therapeutics reported revenue of
$79.36MM vs $18.22MM (up 335.66%) and diluted earnings per share
-$2.42 vs -$2.72. Juno Therapeutics is expected to report earnings
on March 7th, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was -$0.66. The estimated EPS forecast for the next fiscal
year is -$4.40 and is expected to report on March 7th, 2018.
To read the full Juno Therapeutics, Inc. (JUNO) report, download
it here:
http://Fundamental-Markets.com/register/?so=JUNO
-----------------------------------------
ABBOTT LABORATORIES (ABT) REPORT OVERVIEW
Abbott Laboratories' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Abbott Laboratories reported revenue of
$6,829.00MM vs $5,302.00MM (up 28.80%) and diluted earnings per
share $0.34 vs -$0.22. For the twelve months ended December 31st,
2016 vs December 31st, 2015, Abbott Laboratories reported revenue
of $20,853.00MM vs $20,405.00MM (up 2.20%) and diluted earnings per
share $0.94 vs $2.92 (down 67.81%). Abbott Laboratories is expected
to report earnings on January 24th, 2018. The report will be for
the fiscal period ending December 31st, 2017. The reported EPS for
the same quarter last year was $0.65. The estimated EPS forecast
for the next fiscal year is $2.83 and is expected to report on
January 24th, 2018.
To read the full Abbott Laboratories (ABT) report, download it
here:
http://Fundamental-Markets.com/register/?so=ABT
-----------------------------------------
FREEPORT-MCMORAN, INC. (FCX) REPORT
OVERVIEW
Freeport-McMoran's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Freeport-McMoran reported revenue of
$4,310.00MM vs $3,877.00MM (up 11.17%) and diluted earnings per
share $0.19 vs $0.16 (up 18.75%). For the twelve months ended
December 31st, 2016 vs December 31st, 2015, Freeport-McMoran
reported revenue of $14,830.00MM vs $14,607.00MM (up 1.53%) and
diluted earnings per share -$3.16 vs -$11.31. Freeport-McMoran is
expected to report earnings on January 24th, 2018. The report will
be for the fiscal period ending December 31st, 2017. The reported
EPS for the same quarter last year was $0.25. The estimated EPS
forecast for the next fiscal year is $1.63 and is expected to
report on January 24th, 2018.
To read the full Freeport-McMoran, Inc. (FCX) report, download
it here:
http://Fundamental-Markets.com/register/?so=FCX
-----------------------------------------
HP INC. (HPQ) REPORT OVERVIEW
HP's Recent Financial Performance
For the three months ended July 31st, 2017 vs
July 31st, 2016, HP reported revenue of $13,060.00MM vs
$11,892.00MM (up 9.82%) and diluted earnings per share $0.41 vs
$0.45 (down 8.89%). For the twelve months ended October 31st, 2016
vs October 31st, 2015, HP reported revenue of $48,238.00MM vs
$51,463.00MM (down 6.27%) and diluted earnings per share $1.43 vs
$2.48 (down 42.34%). HP is expected to report earnings on February
28th, 2018. The report will be for the fiscal period ending January
31st, 2018. The reported EPS for the same quarter last year was
$0.38. The estimated EPS forecast for the next fiscal year is $1.90
and is expected to report on November 20th, 2018.
To read the full HP Inc. (HPQ) report, download it here:
http://Fundamental-Markets.com/register/?so=HPQ
-----------------------------------------
THE TRADE DESK INC. (TTD) REPORT
OVERVIEW
The Trade Desk's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, The Trade Desk reported revenue of
$79.41MM vs $52.96MM (up 49.96%) and diluted earnings per share
$0.23 vs $0.06 (up 283.33%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, The Trade Desk reported revenue
of $202.93MM vs $113.84MM (up 78.26%) and diluted earnings per
share -$1.46 vs $0.39. The Trade Desk is expected to report
earnings on February 15th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.24. The estimated EPS forecast for the
next fiscal year is $1.24 and is expected to report on February
15th, 2018.
To read the full The Trade Desk Inc. (TTD) report, download it
here:
http://Fundamental-Markets.com/register/?so=TTD
-----------------------------------------
PLATFORM SPECIALTY PRODUCTS CORPORATION (PAH) REPORT
OVERVIEW
Platform Specialty Products' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Platform Specialty Products reported
revenue of $904.30MM vs $890.50MM (up 1.55%) and diluted earnings
per share -$0.24 vs -$0.15. For the twelve months ended December
31st, 2016 vs December 31st, 2015, Platform Specialty Products
reported revenue of $3,585.90MM vs $2,542.30MM (up 41.05%) and
diluted earnings per share -$0.65 vs -$1.52. Platform Specialty
Products is expected to report earnings on February 27th, 2018. The
report will be for the fiscal period ending December 31st, 2017.
The reported EPS for the same quarter last year was $0.20. The
estimated EPS forecast for the next fiscal year is $0.94 and is
expected to report on February 27th, 2018.
To read the full Platform Specialty Products Corporation (PAH)
report, download it here:
http://Fundamental-Markets.com/register/?so=PAH
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Feb 2024 to Mar 2024
JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Mar 2023 to Mar 2024